SEP 21, 2017 10:29 AM PDT

Immune Cells Patch Up Holes in the Gut

WRITTEN BY: Kara Marker

Immune cells are capable of making repairs in an intestine damaged by inflammatory bowel diseases. Either by boosting the activity of these cells or mimicking their reparative mechanisms, researchers believe they can develop a new treatment for those afflicted.

Credit: Georgia State University

Inflammatory bowel disease, which includes Crohn’s disease and ulcerative colitis, is generally characterized by a disruption of the integrity of the intestinal epithelial barrier, a layer of tissue that prevents things traveling through the gut from reaching the rest of the body. Bacteria enter the intestine, breeze through the barrier, and trigger an immune response, causing excessive inflammation indicative of inflammatory bowel disease.

Thus, repairing the epithelial barrier is vital for healing the intestines and ridding the body of this disease. From Georgia State University, researchers found that immune cells called macrophages can produce interleukin 10 (IL-10), which works as a healing factor in the context of inflammatory bowel disease. IL-10 works its magic by interacting with receptors on intestinal epithelial cells to promote wound healing.

“We tried to understand some of the cellular mechanisms that are required for optimal wound healing in the intestine,” explained Dr. Dim Denning. “To do this, we used a cutting-edge system, a colonoscope with biopsy forceps, to create a wound in mice.”

Denning’s system used in mice mimics colonoscopies commonly conducted in humans. “This cutting-edge system allowed us to begin to define what cells and factors contribute to wound healing in the mouse model,” Denning said.

Specifically, Denning and his team compared normal (wild-type) mice with mice genetically deficient in IL-10, particularly the macrophages, looking at the ability of each group to repair epithelial wounds. Without IL-10, the mice were largely inept at wound-healing in the intestines.

Based on this finding, Denning believes that there is potential for new therapeutic interventions for people with inflammatory bowel disease.

"There are different ways we think about it, but perhaps we could deliver the beneficial compounds (IL-10 and the downstream signaling pathways) to those patients, orally or even intravenously, or somehow drive the natural production of those compounds,” he said.

The present study was published in The Journal of Clinical Investigation.

Sources: Georgia State University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 15, 2021
Immunology
Your Immune System Can't Deal With All the Plastic You're Eating
JUL 15, 2021
Your Immune System Can't Deal With All the Plastic You're Eating
Microplastics—tiny fragments of plastic, less than five millimeters in diameter—pollute our environment and, ...
JUL 30, 2021
Cancer
Obesity Reduces Mortality in Advanced Prostate Cancer
JUL 30, 2021
Obesity Reduces Mortality in Advanced Prostate Cancer
Obese patients with an advanced form of prostate cancer survive longer than their slimmer counterparts, according to res ...
SEP 09, 2021
Cancer
Can a Mole Fight Melanoma?
SEP 09, 2021
Can a Mole Fight Melanoma?
About 30% of melanoma cases arise from an existing nevus.  More commonly known as moles, Nevi are skin growths that ...
SEP 23, 2021
Immunology
Enhanced Hamster Cells as Super Drug Factories
SEP 23, 2021
Enhanced Hamster Cells as Super Drug Factories
Antibodies are highly specialized proteins produced by the immune system that stick on to foreign invaders in the body w ...
SEP 23, 2021
Cardiology
Curbing Adverse Cardiovascular Outcomes Through Influenza Vaccination
SEP 23, 2021
Curbing Adverse Cardiovascular Outcomes Through Influenza Vaccination
Influenza is a severe infectious disease. According to the Centers for Disease Control and Prevention the H1N1 strain of ...
OCT 14, 2021
Genetics & Genomics
RSV Infections Can Modify Host Immune Gene Activity
OCT 14, 2021
RSV Infections Can Modify Host Immune Gene Activity
Respiratory syncytial virus (RSV) are thought to be incredibly common; research has suggested that almost everyone is ev ...
Loading Comments...